Cite
Identification of markers that functionally define a quiescent multiple myeloma cell sub-population surviving bortezomib treatment.
MLA
Adomako, Alfred, et al. “Identification of Markers That Functionally Define a Quiescent Multiple Myeloma Cell Sub-Population Surviving Bortezomib Treatment.” BMC Cancer, vol. 15, no. 1, June 2015, pp. 1–11. EBSCOhost, https://doi.org/10.1186/s12885-015-1460-1.
APA
Adomako, A., Calvo, V., Biran, N., Osman, K., Chari, A., Paton, J. C., Paton, A. W., Moore, K., Schewe, D. M., & Aguirre-Ghiso, J. A. (2015). Identification of markers that functionally define a quiescent multiple myeloma cell sub-population surviving bortezomib treatment. BMC Cancer, 15(1), 1–11. https://doi.org/10.1186/s12885-015-1460-1
Chicago
Adomako, Alfred, Veronica Calvo, Noa Biran, Keren Osman, Ajai Chari, James C. Paton, Adrienne W. Paton, Kateri Moore, Denis M. Schewe, and Julio A. Aguirre-Ghiso. 2015. “Identification of Markers That Functionally Define a Quiescent Multiple Myeloma Cell Sub-Population Surviving Bortezomib Treatment.” BMC Cancer 15 (1): 1–11. doi:10.1186/s12885-015-1460-1.